Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FABRAZYME
- A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
- Switch Over Study of Biosimilar AGA for Fabry Disease
- China Post-marketing Surveillance (PMS) Study of Fabrazyme®
- To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Versus Continuing on Agalsidase Alfa (Replagal) in Male Patients With Classic Fabry Disease
- A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease
- Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients.
- Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease
- Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease
- The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
- A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.
- A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.
- A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease
- A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease
Clinical trials list
click for details